Benefits of estrogen therapy stack up
May 3, 1998
Web posted at: 4:59 p.m. EDT (2059 GMT)
ATLANTA (CNN) -- Two recent studies on estrogen treatments
indicate the growing importance for women to weigh the risks
and benefits of post-menopausal hormone replacement therapy.
Estrogen therapies are controversial in part because studies
show estrogen can increase the risk of breast cancer.
But the benefits of taking estrogen after menopause keep
stacking up.
Two recent studies show estrogen can lower the risk of colo-rectal cancer and reduce the severity of symptoms of Parkinson's disease.
Estrogen and colo-rectal cancer
Researchers at Harvard University found post-menopausal women
who took hormones could significantly lower their risk for
colo-rectal cancer.
"We found that the women ... had a 35 percent lower risk of
colo-rectal cancer than women who had never taken hormones,"
said Francine Grodstein of Brigham and Women's Hospital, which is associated with the university.
Cancer of the colon and rectum is the second-biggest cancer
killer, but the colo-rectal cancer rate is decreasing.
Doctors say survival rates are increasing. They also say a
healthy diet and regular exercise can also lower your chances
of getting colo-rectal cancer.
Estrogen and Parkinson's disease
Researchers at Columbia-Presbyterian Medical Center in New
York found estrogen taken by post-menopausal women can be
beneficial to women who suffer from Parkinson's disease.
"Hormone replacement may actually benefit women with early
Parkinson's disease who are not yet on levodopa," said Dr.
Rachel Saunders-Pullman of the medical center.
|
|
Zell's daily physical therapy session
| |
Levodopa is the most common treatment for Parkinson's
disease.
Gloria Zell, a Parkinson's patient, told CNN she's been on
levodopa for 20 years. Zell tried the estrogen treatment,
too, but didn't get any extra relief.
"It just did nothing for me, one way or the other, so I
stopped," Zell said about her estrogen treatments.
Other studies have shown that estrogen can worsen symptoms in
some Parkinson's patients.
Correspondent Al Hinman contributed to this report.